Literature DB >> 19022739

Molecular mechanism for generation of antibody memory.

Velizar Shivarov1, Reiko Shinkura, Tomomitsu Doi, Nasim A Begum, Hitoshi Nagaoka, Il-Mi Okazaki, Satomi Ito, Taichiro Nonaka, Kazuo Kinoshita, Tasuku Honjo.   

Abstract

Activation-induced cytidine deaminase (AID) is the essential enzyme inducing the DNA cleavage required for both somatic hypermutation and class switch recombination (CSR) of the immunoglobulin gene. We originally proposed the RNA-editing model for the mechanism of DNA cleavage by AID. We obtained evidence that fulfils three requirements for CSR by this model, namely (i) AID shuttling between nucleus and cytoplasm, (ii) de novo protein synthesis for CSR, and (iii) AID-RNA complex formation. The alternative hypothesis, designated as the DNA-deamination model, assumes that the in vitro DNA deamination activity of AID is representative of its physiological function in vivo. Furthermore, the resulting dU was removed by uracil DNA glycosylase (UNG) to generate a basic site, followed by phosphodiester bond cleavage by AP endonuclease. We critically examined each of these provisional steps. We identified a cluster of mutants (H48A, L49A, R50A and N51A) that had particularly higher CSR activities than expected from their DNA deamination activities. The most striking was the N51A mutant that had no ability to deaminate DNA in vitro but retained approximately 50 per cent of the wild-type level of CSR activity. We also provide further evidence that UNG plays a non-canonical role in CSR, namely in the repair step of the DNA breaks. Taking these results together, we favour the RNA-editing model for the function of AID in CSR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19022739      PMCID: PMC2660911          DOI: 10.1098/rstb.2008.0183

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  52 in total

1.  DNA deamination mediates innate immunity to retroviral infection.

Authors:  Reuben S Harris; Kate N Bishop; Ann M Sheehy; Heather M Craig; Svend K Petersen-Mahrt; Ian N Watt; Michael S Neuberger; Michael H Malim
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice.

Authors:  Cristina Rada; Gareth T Williams; Hilde Nilsen; Deborah E Barnes; Tomas Lindahl; Michael S Neuberger
Journal:  Curr Biol       Date:  2002-10-15       Impact factor: 10.834

3.  De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination.

Authors:  Tomomitsu Doi; Kazuo Kinoshita; Masaya Ikegawa; Masamichi Muramatsu; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

4.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.

Authors:  Svend K Petersen-Mahrt; Reuben S Harris; Michael S Neuberger
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

5.  Transcription-targeted DNA deamination by the AID antibody diversification enzyme.

Authors:  Jayanta Chaudhuri; Ming Tian; Chan Khuong; Katrin Chua; Eric Pinaud; Frederick W Alt
Journal:  Nature       Date:  2003-04-09       Impact factor: 49.962

6.  Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand.

Authors:  Almudena R Ramiro; Pete Stavropoulos; Mila Jankovic; Michel C Nussenzweig
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

7.  Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation.

Authors:  Phuong Pham; Ronda Bransteitter; John Petruska; Myron F Goodman
Journal:  Nature       Date:  2003-06-18       Impact factor: 49.962

8.  Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase.

Authors:  Ronda Bransteitter; Phuong Pham; Matthew D Scharff; Myron F Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

9.  Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations.

Authors:  Anjum Sohail; Joanna Klapacz; Mala Samaranayake; Asad Ullah; Ashok S Bhagwat
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

10.  AID mediates hypermutation by deaminating single stranded DNA.

Authors:  Sarah K Dickerson; Eleonora Market; Eva Besmer; F Nina Papavasiliou
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

View more
  4 in total

1.  Subversion of innate and adaptive immune activation induced by structurally modified lipopolysaccharide from Salmonella typhimurium.

Authors:  Rodolfo Pastelin-Palacios; Cristina Gil-Cruz; Christian I Pérez-Shibayama; Mario A Moreno-Eutimio; Luisa Cervantes-Barragán; Lourdes Arriaga-Pizano; Burkhard Ludewig; Adam F Cunningham; Eduardo A García-Zepeda; Ingeborg Becker; Celia Alpuche-Aranda; Laura Bonifaz; John S Gunn; Armando Isibasi; Constantino López-Macías
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

2.  Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer.

Authors:  Ayako Goto; Minako Hirahashi; Mikako Osada; Kazuhiko Nakamura; Takashi Yao; Masazumi Tsuneyoshi; Ryoichi Takayanagi; Yoshinao Oda
Journal:  Virchows Arch       Date:  2011-05-03       Impact factor: 4.064

3.  AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.

Authors:  Anastasia Meshcheryakova; Peter Pietschmann; Philip Zimmermann; Igor B Rogozin; Diana Mechtcheriakova
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

4.  High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif.

Authors:  Taku Tsukamoto; Masakazu Nakano; Ryuichi Sato; Hiroko Adachi; Miki Kiyota; Eri Kawata; Nobuhiko Uoshima; Satoru Yasukawa; Yoshiaki Chinen; Shinsuke Mizutani; Yuji Shimura; Tsutomu Kobayashi; Shigeo Horiike; Akio Yanagisawa; Masafumi Taniwaki; Kei Tashiro; Junya Kuroda
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.